Trials / Completed
CompletedNCT05244395
Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy
Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy: Gait Assessment Scale for Duchenne Muscular Dystrophy, and Its Validity and Reliability
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Hacettepe University · Academic / Other
- Sex
- Male
- Age
- 5 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to develop a gait assessment instrument for Duchenne Muscular Dystrophy patients (DMD-GAS), and investigate its validity and reliability.The scale was developed considering the expert opinions which included 10 physiotherapists who had experience in the management of patients with DMD over the 2-round Delphi method, and the Content Validity Index (CVI) was calculated. The final version of the DMD-GAS that was agreed upon the experts consisted of 10 items, and each item scored between 0 and 2. The intra-rater reliability was established by the video analysis of children with a 1-month interval and inter-rater reliability was determined by the scores of 3 physiotherapists. The criterion validity was determined by investigating the relationship between the total score of the DMD-GAS and Motor Function Measure (MFM), 6 Minute Walk Test (6MWT), and the data obtained from GAITRite system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Duchenne Muscular Dystrophy Gait Assessment Scale | a special gait assessment scale for Duchenne Muscular Dystrophy patients |
Timeline
- Start date
- 2020-02-10
- Primary completion
- 2021-11-30
- Completion
- 2022-02-10
- First posted
- 2022-02-17
- Last updated
- 2022-03-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05244395. Inclusion in this directory is not an endorsement.